You are here

Influenza reagents

16 January 2020

The TGA as a World Health Organisation (WHO) designated Essential Regulatory Laboratory (ERL), supplies influenza reference reagents used for testing influenza vaccines globally to vaccine manufacturers, other regulatory agencies and research organisations.

Influenza reagents

Overview of ordering process

  • Completed order form with all required documentation (purchase orders, permits if required) submitted to TGA.
  • Required shipping documentation is drafted by TGA.
  • The order is forwarded to the Logistics team.
  • 'Processing update notification' sent to the contacts listed in the order form advising that the order has been progressed to the logistics team for the next stage of processing.
  • The Logistics team liaise with nominated courier to arrange preclearance* and coordinate collection of shipment.
    • *not all courier companies pre-clear shipping documentation
  • Nominated courier request authorisation from the customer, to charge the shipping cost to the nominated account (when this authorisation is requested it must come directly from the customer to the courier for the specific shipment).
  • Shipment collected by the nominated courier company and transported on dry ice to the customer
    • All TGA Influenza reference reagents are shipped on dry-ice, it is the responsibility of the ordering company to ensure that the nominated courier is able to handle shipments containing dry-ice.
  • Logistics team sends a dispatch notification to customer with details of shipment, including airway bill details for tracking the shipment when it is dispatched.
  • Tax invoice is raised and issued to customer.
  • Payment received

For any enquiries or communication regarding TGA Influenza Reference Reagents, email influenza.reagents@health.gov.au. If your enquiry relates to a submitted order, please ensure the purchase order number is included in the subject of the email.

Supply agreement

All TGA Influenza Reference reagents are supplied in accordance with the conditions outlined in the Supply Agreement, acceptance of these terms and conditions is required for your order to be submitted.

How to access a pdf or Word document

Order reagents

Details of the TGA Influenza Reference reagents currently available for supply are available below. To place an order for any of these reagents please use the online order form.

How to access a pdf or Word document

Seasonal reagents currently available

Minimum order quantity 10 units.

The instructions for use are available below in PDF and Word format. Email influenza.reagents@health.gov.au if you require one of these documents in a different format.

A/Brisbane/02/2018 (H1N1) pdm09–like virus
Parental Virus Reagent Lot Volume Instructions for use
A/Brisbane/02/2018 (IVR-190) Reference Antigen 2019/127B 0.5g vial

IFU: Lot 2019/127B (pdf,166kb)

IFU: Lot 2019/127B (docx,232kb)

Antigen 2019/131B 0.5g vial

IFU: Lot 2019/131B (pdf,176kb)

IFU: Lot 2019/131B (docx,223kb)

Antiserum AS430-1 0.5mL vial

IFU: Lot AS430-1 (pdf,153kb)

IFU: Lot AS430-1 (docx,228kb)

A/Michigan/45/2015 (H1N1)pdm09-like virus
Parental Virus Reagent Lot Volume Instructions for use
A/Singapore/GP1908/2015 (IVR-180) Reference Antigen 2016/112B 0.5g vial

IFU: Lot 2016/112B (pdf,178kb)

IFU: Lot 2016/112B (docx,230kb)

Antiserum AS418 0.5mL vial

IFU: Lot AS418 (pdf,157kb)

IFU: Lot AS418 (docx,227kb)

A/Singapore/GP1908/2015 Reference Antigen (Cell propagated) 2016/114B 0.5g vial

IFU: Lot 2016/114B (pdf,177kb)

IFU: Lot 2016/114B (docx,229kb)

A/Singapore/GP1908/2015 (IVR-180A) Reference Antigen 2017/118B 0.5g vial

IFU: Lot 2017/118B (pdf,206kb)

IFU: Lot 2017/118B (docx,230kb)

A/Singapore/GP1908/2015 (IVR-180) Reference Antigen (Cell propagated) 2017/119B 0.5g vial

IFU: Lot 2017/119B (pdf,205kb)

IFU: Lot 2017/119B (docx,229kb)

A/South Australia/34/2019 (H3N2)-like virus
Parental Virus Reagent Lot Volume Instructions for use
A/South Australia/34/2019 (IVR-197) Reference Antigen 2019/129B 0.5g

IFU: Lot 2019/129B (pdf,177kb)

IFU: Lot 2019/129B (docx,224kb)

A/South Australia/34/2019-like Antiserum AS437 0.5mL

IFU: Lot AS437 (pdf,154kb)

IFU: Lot AS437 (docx,221kb)

A/Kansas/14/2017 (H3N2)-like virus
Parental Virus Reagent Lot Volume Instructions for use
A/Kansas/14/2017 (X-327) Reference Antigen 2019/128B 0.5g

IFU: Lot 2019/128B (pdf,167kb)

IFU: Lot 2019/128B (docx,229kb)

A/Kansas/14/2017-like Antiserum AS433 0.5mL

IFU: Lot AS433 (pdf,153kb)

IFU: Lot AS433 (docx,229kb)

A/Switzerland/8060/2017 like Virus
Parental Virus Reagent Lot Volume Instructions for use
A/Brisbane/1/2018 (X-311) Reference Antigen 2018/125B 0.5g vial

IFU: Lot 2018/125B (pdf,163kb)

IFU: Lot 2018/125B (docx,229kb)

Antiserum AS428 0.5mL vial

IFU: Lot AS428 (pdf,148kb)

IFU: Lot AS428 (docx,227kb)

A/Singapore/INFIMH-16-0019/2016-like virus
Parental Virus Reagent Lot Volume Instructions for use
A/Singapore/INFIMH-16-0019/2016 (IVR-186) Reference Antigen 2018/123B 0.5g vial

IFU: Lot 2018/123B (pdf,164kb)

IFU: Lot 2018/123B (docx,229kb)

Antiserum AS420-1 0.5mL vial

IFU: Lot AS420-1 (pdf,146kb)

IFU: Lot AS420-1 (docx,228kb)

AS424 0.5mL vial

IFU: Lot AS424 (pdf,147kb)

IFU: Lot AS424 (docx,228kb)

A/Hong Kong/4801/2014 (H3N2)-like viruses
Parental Virus Reagent Lot Volume Instructions for use
A/Singapore/GP2050/2015 Reference Antigen (Cell propagated) 2017/116B 0.5g vial

IFU: Lot 2017/116B (pdf,164kb)

IFU: Lot 2017/116B (docx,230kb)

B/Washington/02/2019-like (B/Victoria linage)
Parental Virus Reagent Lot Volume Instructions for use
B/Victoria/705/2018 (BVR-11) Reference Antigen 2019/130B 0.5g vial

IFU: Lot 2019/130B (pdf,177kb)

IFU: Lot 2019/130B (docx,223kb)

B/Washington/02/2019-like Antiserum AS436 0.5g vial

IFU: Lot AS436 (pdf,157kb)

IFU: Lot AS436 (docx,221kb)

B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage)
Parental Virus Reagent Lot Volume Instructions for use
B/Colorado/06/2017 Reference Antigen 2018/124B 0.5g vial

IFU: Lot 2018/124B (pdf,163kb)

IFU: Lot 2018/124B (docx,229kb)

Antiserum AS429 0.5mL vial

IFU: Lot AS429 (pdf,147kb)

IFU: Lot AS429 (docx,228kb)

B/Maryland/15/2016 Reference Antigen 2018/122B 0.5g vial

IFU: Lot 2018/122B (pdf,162kb)

IFU: Lot 2018/122B (docx,229kb)

Antiserum AS422 0.5mL vial

IFU: Lot AS422 (pdf,146kb)

IFU: Lot AS422 (docx,227kb)

B/Phuket/3073/2013-like (B/Yamagata/16/88 lineage)
Parental Virus Reagent Lot Volume Instructions for use
B/Phuket/3073/2013 Reference Antigen 2017/115B 0.5g vial

IFU: Lot 2017/115B (pdf,162kb)

IFU: Lot 2017/115B (docx,230kb)

B/Wisconsin/1/2010(BX-41A) Antiserum AS426 0.5mL vial

IFU: Lot AS426 (pdf,149kb)

IFU: Lot AS426 (docx,227kb)

B/Phuket/3073/2013 (BVR-1B) Reference Antigen 2017/117B 0.5g vial

IFU: Lot 2017/117B (pdf,163kb)

IFU: Lot 2017/117B (docx,230kb)

Antiserum AS425 0.5mL vial

IFU: Lot AS425 (pdf,148kb)

IFU: Lot AS425 (docx,228kb)

Antiserum AS434 0.5mL vial

IFU: Lot AS434 (pdf,151kb)

IFU: Lot AS434 (docx,222kb)

Pandemic reagents currently available

Parental Virus Reagent Lot Volume Instructions for use
A/Indonesia/5/2005 (IBCDC-RG2) Antiserum AS406 0.5mL vial

IFU: Lot AS406 (pdf,157kb)

IFU: Lot AS406 (docx,229kb)

A/Egypt/N03072/2010 (IDCDC-RG29) Reference Antigen 2016/110B 0.5g vial

IFU: Lot 2016/110B (pdf,163kb)

IFU: Lot 2016/110B (docx,230kb)

Antiserum AS414 0.5mL vial

IFU: Lot AS414 (pdf,158kb)

IFU: Lot AS414 (docx,229kb)

A/turkey/Turkey/1/2005 (NIBRG-23) Antiserum AS421 0.5mL vial

IFU: Lot AS421 (pdf,151kb)

IFU: Lot AS421 (docx,228kb)

Parental Virus Reagent Lot Volume Instructions for use
A/Shanghai/2/2013 (IDCDC-RG32A) Reference Antigen 2014/100B 0.5g vial

IFU: Lot 2014/100B (pdf,162kb)

IFU: Lot 2014/100B (docx,229kb)

Past reagents Instructions For Use

A/Brisbane/02/2018 (H1N1) pdm09–like virus
Parental Virus Reagent Lot Volume Instructions for use
A/Brisbane/02/2018 (IVR-190) Antiserum AS430 0.5mL vial

IFU: Lot AS430 (pdf,158kb)

IFU: Lot AS430 (docx,228kb)